Clinical Trial Update: Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pentoxifylline and tocopherol for liver fibrosis in chronic hepatitis C was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Fibrosis

Drugs mentioned

• Pentoxifylline (pentoxifylline)
• Tocopherol (Vitamin E)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Hepatitis C, Chronic, Liver Fibrosis | Phase 3 | Status: TERMINATED